The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64

• Published in: Oncogene Vol. 19; no. 28; pp. 3182 - 3192
• Main Authors: CORMIER, R. T, BILGER, A, LILLICH, A. J, HALBERG, R. B, HONG, K. H, GOULD, K. A, BORENSTEIN, N, LANDER, E. S, DOVE, W. F
• Format: Journal Article
• Language: English
• Published: Basingstoke Nature Publishing 29.06.2000; Nature Publishing Group
• Subjects: Adenomatous Polyposis Coli - genetics; Adenomatous Polyposis Coli Protein; Animals; Biological and medical sciences; Cell physiology; Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes; Chromosome 4; Chromosomes; Cytoskeletal Proteins - genetics; Female; Fundamental and applied biological sciences. Psychology; Genes; Genotype & phenotype; Goblet cells; Goblet Cells - pathology; Humans; Immunity, Innate - genetics; Intestines - pathology; Large intestine; Male; Medical research; Mice; Mice, Inbred AKR; Mice, Inbred C57BL; Mice, Transgenic; Molecular and cellular biology; Mutation; Phenotypes; Phospholipases A - biosynthesis; Phospholipases A - genetics; Recombinants; Small intestine; Transgenic mice; Tumorigenesis; Tumors; Ultrastructure; United States > US; Massachusetts; Wisconsin; Nebraska; Genetic mapping; Enzyme; Rodentia; Gut; Transgenic animal; Esterases; Chromosome 4; Modifier gene; Malignant tumor; Carcinogenesis; Resistance; Phospholipase; Vertebrata; Mammalia; Cell line; Mouse; Hydrolases; Tumor suppressor gene; Polymorphism
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/sj.onc.1203646

The Mom1 (Modifier of Min-1) region of distal chromosome 4 was identified during a screen for polymorphic modifiers of intestinal tumorigenesis in ApcMin/+ mice. Here, we demonstrate that the Mom1AKR allele consists of two genetic components. These include the secretory phospholipase Pla2g2a, whose candidacy as a Mom1 resistance modifier has now been tested with several transgenic lines. A second region, distal to Pla2g2a, has also been identified using fine structure recombinants. Pla2g2aAKR transgenic mice demonstrate a modest resistance to tumorigenesis in the small intestine and a very robust resistance in the large intestine. Moreover, the tumor resistance in the colon of Pla2g2aAKR animals is dosage-dependent, a finding that is consistent with our observation that Pla2g2a is expressed in goblet cells. By contrast, mice carrying the distal Mom1 modifier demonstrate a modest tumor resistance that is confined to the small intestine. Thus, the phenotypes of these two modifier loci are complementary, both in their quantitative and regional effects. The additive effects and tight linkage of these modifiers may have been necessary for the initial identification of the Mom1 region.